dihexa usp nuBioAge - 30 Capsules Dihexa (PNB-0408) | c-Met/HGFR Activator

Because Dihexa lacked pharmaceutical-grade drug-like properties for clinical development, Athira Pharma instead developed fosgonimeton (ATH-1017), a phosphate prodrug that is rapidly converted to an active HGF/c-Met-potentiating metabolite following subcutaneous administration

The application of NaBPC157 leads to significantly reduced pathomorphological findings of antracyclin cardiomyopathy (severe damage of myocytes and vessel walls, and vacuolisation) after single, and in greater extent, after multiple doxorubicin administration

Inflammation and pain represent an organisms response to tissue damage and are inextricably linked

Chaudhary A, Maurya PK, Yadav BS et al (2018) Current therapeutic targets for Alzheimers disease